United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $14.27 billion. The enterprise value is $9.88 billion.
| Market Cap | 14.27B |
| Enterprise Value | 9.88B |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, before market open.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 44.91 million shares outstanding. The number of shares has decreased by -2.41% in one year.
| Current Share Class | 44.91M |
| Shares Outstanding | 44.91M |
| Shares Change (YoY) | -2.41% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 94.13% |
| Float | 41.32M |
Valuation Ratios
The trailing PE ratio is 12.88 and the forward PE ratio is 11.67.
| PE Ratio | 12.88 |
| Forward PE | 11.67 |
| PS Ratio | 5.07 |
| Forward PS | 4.48 |
| PB Ratio | 2.25 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | 13.22 |
| P/OCF Ratio | 10.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.51, with an EV/FCF ratio of 9.14.
| EV / Earnings | 8.27 |
| EV / Sales | 3.43 |
| EV / EBITDA | 6.51 |
| EV / EBIT | 6.83 |
| EV / FCF | 9.14 |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.25 |
| Quick Ratio | 4.80 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.31 |
| Interest Coverage | 33.71 |
Financial Efficiency
Return on equity (ROE) is 19.23% and return on invested capital (ROIC) is 13.42%.
| Return on Equity (ROE) | 19.23% |
| Return on Assets (ROA) | 12.44% |
| Return on Invested Capital (ROIC) | 13.42% |
| Return on Capital Employed (ROCE) | 21.83% |
| Revenue Per Employee | $221.34M |
| Profits Per Employee | $91.93M |
| Employee Count | 13 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, UTHR has paid $343.90 million in taxes.
| Income Tax | 343.90M |
| Effective Tax Rate | 22.35% |
Stock Price Statistics
The stock price has increased by +35.53% in the last 52 weeks. The beta is 0.64, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +35.53% |
| 50-Day Moving Average | 347.82 |
| 200-Day Moving Average | 345.23 |
| Relative Strength Index (RSI) | 43.72 |
| Average Volume (20 Days) | 628,653 |
Short Selling Information
The latest short interest is 2.07 million, so 4.60% of the outstanding shares have been sold short.
| Short Interest | 2.07M |
| Short Previous Month | 2.01M |
| Short % of Shares Out | 4.60% |
| Short % of Float | 5.00% |
| Short Ratio (days to cover) | 4.69 |
Income Statement
In the last 12 months, UTHR had revenue of $2.88 billion and earned $1.20 billion in profits. Earnings per share was $24.64.
| Revenue | 2.88B |
| Gross Profit | 2.57B |
| Operating Income | 1.45B |
| Pretax Income | 1.40B |
| Net Income | 1.20B |
| EBITDA | 1.52B |
| EBIT | 1.45B |
| Earnings Per Share (EPS) | $24.64 |
Balance Sheet
The company has $3.27 billion in cash and $338.60 million in debt, giving a net cash position of $4.40 billion or $98.05 per share.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 338.60M |
| Net Cash | 4.40B |
| Net Cash Per Share | $98.05 |
| Equity (Book Value) | 6.44B |
| Book Value Per Share | 143.74 |
| Working Capital | 3.14B |
Cash Flow
In the last 12 months, operating cash flow was $1.33 billion and capital expenditures -$246.50 million, giving a free cash flow of $1.08 billion.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -246.50M |
| Free Cash Flow | 1.08B |
| FCF Per Share | $24.06 |
Margins
Gross margin is 89.24%, with operating and profit margins of 50.26% and 41.53%.
| Gross Margin | 89.24% |
| Operating Margin | 50.26% |
| Pretax Margin | 53.49% |
| Profit Margin | 41.53% |
| EBITDA Margin | 52.78% |
| EBIT Margin | 50.26% |
| FCF Margin | 37.55% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.41% |
| Shareholder Yield | 2.41% |
| Earnings Yield | 8.37% |
| FCF Yield | 7.56% |
Analyst Forecast
The average price target for UTHR is $388.25, which is 22.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $388.25 |
| Price Target Difference | 22.19% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 7.86% |
| EPS Growth Forecast (5Y) | 18.59% |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 11.75 and a Piotroski F-Score of 7.
| Altman Z-Score | 11.75 |
| Piotroski F-Score | 7 |